loading
Overview News Price History Option Chain Financials Why AVDL Down? Discussions Forecast

Why is Avadel Pharmaceuticals Plc (AVDL) Stock down?

We've noticed a 26.10% decline in Avadel Pharmaceuticals Plc (AVDL) stock during the 2025-01-10 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
23 Jun, 2023:

AVDL's stock fell 11.41% following Jazz Pharmaceuticals' lawsuit against the FDA for violating the orphan drug exclusivity of Xywav by approving Avadel Pharmaceuticals' Lumryz, which is an extended-release reformulation of its high sodium oxybate product Xyrem for narcolepsy.

https://www.benzinga.com/general/biotech/23/06/32982101/jazz-pharmaceuticals-sues-fda-over-approval-of-rival-product-calls-it-unlawful

Similar to AVDL

drug_manufacturers_specialty_generic ALKS
$30.10
price up icon 2.14%
drug_manufacturers_specialty_generic ELAN
$12.04
price up icon 0.17%
drug_manufacturers_specialty_generic LNTH
$94.05
price up icon 2.82%
drug_manufacturers_specialty_generic ITCI
$126.50
price up icon 0.24%
drug_manufacturers_specialty_generic VTRS
$11.33
price up icon 0.27%
drug_manufacturers_specialty_generic NBIX
$145.88
price up icon 1.83%
Open in Yahoo | Open in Google | Open in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters
Cap:     |  Volume (24h):